Atrium Therapeutics, Inc. · NASDAQ:RNA

Ra Capital Management, L.P. reported a 5.60% stake in Atrium Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Ra Capital Management, L.P. reported a 5.60% stake in Atrium Therapeutics, Inc., 864,102 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.60%
Shares
864,102
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.5.60%864,102
Peter Kolchinsky5.60%864,102
Rajeev Shah5.60%864,102
RA Capital Healthcare Fund, L.P.5.60%864,102

Source

View original at SEC

Related